Panacea Life Sciences

(OTC) PLSH

Current Price$0.03

Market Cap$567,300

Since IPO (2021)-99%

5 Year-99%

1 Year-24%

1 Month-37%

Panacea Life Sciences Financials at a Glance

Market Cap

$567,300

Revenue (TTM)

$910.52K

Net Income (TTM)

$416.68K

EPS (TTM)

$0.00

P/E Ratio

93.33

Dividend

$0.00

Beta (Volatility)

-5.70 (Low)

Dividend

$0.00

Beta (Volatility)

-5.70 (Low)

Price

$0.03

Volume

13,951

Open

$0.04

Price

$0.03

Volume

13,951

Open

$0.04

Previous Close

$0.03

Daily Range

$0.03 - $0.04

52-Week Range

$0.02 - $0.20

Dividend

$0.00

Beta (Volatility)

-5.70 (Low)

Price

$0.03

Volume

13,951

Open

$0.04

Previous Close

$0.03

Daily Range

$0.03 - $0.04

52-Week Range

$0.02 - $0.20

PLSH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Panacea Life Sciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Leslie Buttorff

Website

www.panacealife.com

Headquarters

Greenwood Village, CO 80121, US

PLSH Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-2%

Net Income Margin

-46%

Return on Equity

Return on Capital

-33%

Return on Assets

-7%

Earnings Yield

1.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$567.30K

Shares Outstanding

20.26M

Volume

13.95K

Avg. Volume

14.37K

Financials (TTM)

Gross Profit

$1.22M

Operating Income

$1.75M

EBITDA

$18.19K

Operating Cash Flow

$617.48K

Capital Expenditure

$0.00

Free Cash Flow

$617.48K

Cash & ST Invst.

$41.43K

Total Debt

$214.75K

Panacea Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$49.74K

-94.6%

Gross Profit

$1.73M

-335.8%

Gross Margin

-34.75%

N/A

Market Cap

$567.30K

N/A

Market Cap/Employee

$14.18K

N/A

Employees

N/A

Net Income

$1.20M

-134.8%

EBITDA

$2.49M

-163.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$173.33K

+98.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$3.28M

-10.3%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$214.75K

-98.0%

Return on Assets

-7.45%

N/A

Return on Invested Capital

-32.58%

N/A

Free Cash Flow

$2.04M

+12.2%

Operating Cash Flow

$2.04M

+14.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KOANResonate Blends, Inc.

KOANResonate Blends, Inc.$0.00+0.00%

CBDYTarget Group Inc.

CBDYTarget Group Inc.$0.00-27.78%

OWPCOne World Products, Inc.

OWPCOne World Products, Inc.$0.01+19.64%

CNNACann American Corp.

CNNACann American Corp.$0.00+0.00%

MJARFMJardin Group, Inc.

MJARFMJardin Group, Inc.$0.00+0.00%

ALIDAllied Corp.

ALIDAllied Corp.$0.00+0.00%

BHNGFBhang Inc.

BHNGFBhang Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About PLSH

What is the current price of Panacea Life Sciences?

Panacea Life Sciences is trading at $0.03 per share.

What is the 52-week range for Panacea Life Sciences?

Over the past 52 weeks, Panacea Life Sciences has traded between $0.02 and $0.20.

How much debt does Panacea Life Sciences have?

As of the most recent reporting period, Panacea Life Sciences reported total debt of $214,753.

How much cash does Panacea Life Sciences have on hand?

Panacea Life Sciences reported $41,426 in cash and cash equivalents in its most recent financial results.

What is Panacea Life Sciences’s dividend yield?

Panacea Life Sciences does not currently have a dividend yield.

Panacea Life Sciences

Panacea Life Sciences Financials at a Glance

PLSH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Panacea Life Sciences

PLSH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Panacea Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PLSH

What is the current price of Panacea Life Sciences?

What is the 52-week range for Panacea Life Sciences?

How much debt does Panacea Life Sciences have?

How much cash does Panacea Life Sciences have on hand?

What is Panacea Life Sciences’s dividend yield?

Premium Investing Services